Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Wolbachia endosymbiont of Brugia malayi | cytochrome b subunit of the bc complex | 0.0499 | 0.2574 | 0.5 |
Toxoplasma gondii | apocytochrome b, putative | 0.0499 | 0.2574 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0393 | 0.1954 | 0.5 |
Brugia malayi | cytochrome b | 0.0305 | 0.1442 | 1 |
Mycobacterium tuberculosis | Probable ubiquinol-cytochrome C reductase QcrB (cytochrome B subunit) | 0.1773 | 1 | 0.5 |
Schistosoma mansoni | cytochrome b | 0.0305 | 0.1442 | 0.5601 |
Onchocerca volvulus | 0.1773 | 1 | 1 | |
Toxoplasma gondii | cytochrome b | 0.0499 | 0.2574 | 1 |
Mycobacterium ulcerans | ubiquinol-cytochrome C reductase QcrB | 0.1773 | 1 | 0.5 |
Plasmodium falciparum | cytochrome b | 0.0499 | 0.2574 | 0.5 |
Schistosoma mansoni | cytochrome b | 0.0499 | 0.2574 | 1 |
Loa Loa (eye worm) | cytochrome b | 0.0305 | 0.1442 | 1 |
Plasmodium vivax | cytochrome b | 0.0499 | 0.2574 | 0.5 |
Echinococcus granulosus | cytochrome B | 0.0499 | 0.2574 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0003 | 0.0019 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0058 | 0.0003 | 0.0019 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
LD99 (functional) | = 0.5 ug ml-1 | Bactericidal activity against Escherichia coli K-12 DM4100 after 2 hrs in presence of protein synthesis inhibitor chloramphenicol treated 10 mins before compound challenge | ChEMBL. | 20855738 |
MIC (functional) | = 0.25 ug ml-1 | Bacteriostatic activity against Escherichia coli K-12 DM4100 | ChEMBL. | 20855738 |
Ratio (functional) | = 2 | Ratio of LD99 for Escherichia coli K-12 DM4100 to MIC for Escherichia coli K-12 DM4100 | ChEMBL. | 20855738 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.